$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
3 Top Dividend Kings to Buy for the Long Haul
07:25am, Monday, 20'th Feb 2023
These companies have more than 150 years of dividend growth between them.
Abbott Laboratories under SEC and FTC investigation over baby-formula business
06:36pm, Friday, 17'th Feb 2023
The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories' baby-formula business, the company said.
Abbott Baby-Formula Business Under Investigation By SEC, FTC
06:24pm, Friday, 17'th Feb 2023
The SEC's enforcement division sent a subpoena to Abbott in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securi
How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
07:02am, Friday, 17'th Feb 2023
A new study published in Science Translational Medicine could introduce a profitable opportunity for makers of seizure drug medications. The discovery has immense medical implications, of course, but
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
04:57pm, Wednesday, 15'th Feb 2023
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at
"It's a layup for a misdemeanor charge," a food safety attorney told Crain's Chicago, though a felony would be harder for investigators to prove.
Which Healthcare Stock Is a Better Pick in 2023?
04:05pm, Tuesday, 14'th Feb 2023
Investor sentiment has improved this year on expectations of less-aggressive interest rate hikes by the Federal Reserve to tame inflation. However, the ongoing macro uncertainty continues to create co
Will Abbott Laboratories Remain A Top Dividend Aristocrat Stock Going Forward?
11:49am, Tuesday, 14'th Feb 2023
ABT has been growing its dividends for OVER half a century and is one of only 37 US stocks to do so. We examine if ABT has ample elbow room to service the dividend.
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
05:30am, Tuesday, 14'th Feb 2023
These stocks may reward you over time.
Abbott (ABT) to Expand Vascular Device Line With New Buyout
12:02pm, Monday, 13'th Feb 2023
Abbott's (ABT) latest deal will help gain access to Cardiovascular System's leading atherectomy device to treat vascular disease.
Dividend Champion, Contender, And Challenger Highlights: Week Of February 12
03:22am, Sunday, 12'th Feb 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
The Dividend Aristocrats Ranked By Quality Scores
09:30am, Saturday, 11'th Feb 2023
The annual rebalancing and subsequent changes to the S&P 500 Dividend Aristocrats Index have produced a new list of 67 dividend growth stocks called the Dividend Aristocrats. I rank the Dividend Arist
Compounders And Dividends: February 2023 Watch List Update
03:35am, Saturday, 11'th Feb 2023
Three companies have been removed from my watchlist and added to the active portfolio. I added four new companies to my watchlist.
Abbott Buying Cardiovascular Systems: Details (ABT)
03:15pm, Friday, 10'th Feb 2023
Abbott (NYSE: ABT) is buying Cardiovascular Systems (CSI). These are the details.
Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million
05:44am, Thursday, 09'th Feb 2023
Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 million, or $20 per share. CSI is a leader in devices
Sign In
Buy ABT